Drug intelligence / Profile preview

MetaWell

Development stage: Unknown
Lead developer: 4UWell
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

MetaWell is a multi-ingredient dietary supplement developed by 4UWell, formulated to support gut health and weight management. It is delivered as an oral powder sachet intended for dissolution in water. The product contains a synergistic blend of probiotics (including *Lacticaseibacillus rhamnosus*, *Limosilactobacillus fermentum*, *Lactobacillus gasseri*, *Bifidobacterium bifidum*, *Saccharomyces boulardii*, and *Bifidobacterium infantis*) and prebiotics like inulin to optimize gut flora and digestion. Additionally, it incorporates L-theanine to promote mental calmness and reduce stress-related eating, and chromium picolinate to assist in blood sugar regulation and appetite control. The supplement aims to boost metabolism and reduce cravings as part of a comprehensive weight management strategy.

Brand names: MetaWell

Targets

INSR (Insulin receptor)GluR (Glutamate receptors)

Beyond the preview

Go deeper on MetaWell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MetaWell.

Explore the full profile